Most Active Stories
- Some billing relief for National Grid customers after bitter winter
- Cortland among counties to pull out of SAFE Act pilot program
- Wegmans takes a stance on genetically modified food
- Groups call growing oil shipments in NY Cuomo's "Keystone" moment
- Nuclear waste facility in political and environmental limbo
Novartis Loses Patent Battle In India
Originally published on Fri April 5, 2013 8:50 am
STEVE INSKEEP, HOST:
NPR's business news starts with a patent ruling that may affect millions.
(SOUNDBITE OF MUSIC)
INSKEEP: The ruling comes from the supreme court of India, a country with a population somewhere north of a billion. The Indian supreme court rejected patent rights claimed by the pharmaceutical giant Novartis. This ruling opens the door for Indian drug makers to produce generic versions of Novartis' lifesaving cancer drugs and will make the medicine more affordable for people in developing nations. Transcript provided by NPR, Copyright NPR.